Filing Details

Accession Number:
0001214659-24-018499
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-06 17:05:55
Reporting Period:
2024-11-04
Accepted Time:
2024-11-06 17:05:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST Biological Products, (No Disgnostic Substances) (2836) 462058888
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755970 John Patrick Finn C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-04 30,000 $0.00 189,483 No 4 A Direct
Common Stock Acquisiton 2024-11-04 27,287 $0.00 216,770 No 4 A Direct
Common Stock Acquisiton 2024-11-04 23,551 $0.00 240,321 No 4 A Direct
Common Stock Disposition 2024-11-04 2,681 $41.56 237,640 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.
  2. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.